TOCILIZUMAB MONOTHERAPY IN PATIENTS WHERE METHOTREXATE IS CONSIDERED INAPPROPRIATE- A CANADIAN COST-UTILITY ANALYSIS
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1919
https://www.valueinhealthjournal.com/article/S1098-3015(16)30204-2/fulltext
Title :
TOCILIZUMAB MONOTHERAPY IN PATIENTS WHERE METHOTREXATE IS CONSIDERED INAPPROPRIATE- A CANADIAN COST-UTILITY ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30204-2&doi=10.1016/j.jval.2016.03.1919
First page :
A235
Section Title :
Muscular-Skeletal Disorders - Cost Studies
Open access? :
No
Section Order :
836